Cargando…
PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients
Considering the vast biological diversity and high mortality rate in high-grade ovarian cancers, identification of novel biomarkers, enabling precise diagnosis and effective, less aggravating treatment, is of paramount importance. Based on scientific literature data, we selected 80 cancer-related ge...
Autores principales: | Dansonka-Mieszkowska, Agnieszka, Szafron, Laura Aleksandra, Kulesza, Magdalena, Stachurska, Anna, Leszczynski, Pawel, Tomczyk-Szatkowska, Agnieszka, Sobiczewski, Piotr, Parada, Joanna, Kulinczak, Mariusz, Moes-Sosnowska, Joanna, Pienkowska-Grela, Barbara, Kupryjanczyk, Jolanta, Chechlinska, Magdalena, Szafron, Lukasz Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307210/ https://www.ncbi.nlm.nih.gov/pubmed/35867729 http://dx.doi.org/10.1371/journal.pone.0271539 |
Ejemplares similares
-
Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2019) -
Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2018) -
Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2015) -
The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome
por: Konopka, Bozena, et al.
Publicado: (2016) -
The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues
por: Szafron, Lukasz Michal, et al.
Publicado: (2015)